CoChat
Sign Up
Cited by 2,161

The DOI matches its Crossref record, with a small difference in title or year; 8 of the 8 references it cites were found in a registry or an index.

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

Cohn, Jay N, Ferrari, Roberto, Sharpe, Norman·2000·Journal of the American College of Cardiology
DOI 10.1016/s0735-1097(99)00630-0
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(99)00630-0

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 123

  1. Packer, 1991, Effect of oral milrinone on mortality in severe chronic heart failure, N Engl J Med, 325, 1468, 10.1056/NEJM199111213252103 · DOI
  2. Massie, 1996, Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure, Circulation, 93, 2128, 10.1161/01.CIR.93.12.2128 · DOI
  3. 1991, The effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 · DOI · Paper page
  4. Waagstein, 1993, Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy, Lancet, 342, 1441, 10.1016/0140-6736(93)92930-R · DOI
  5. Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
  6. 1997, Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease, Lancet, 349, 375, 10.1016/S0140-6736(97)80008-6 · DOI
  7. Garg, 1995, Overview of randomized trials of angiotensin-converting enzyme inhibitors on morbidity and mortality in patients with heart failure, JAMA, 273, 1450, 10.1001/jama.1995.03520420066040 · DOI
  8. 1999, Effect of metoprolol CR/XL in chronic heart failure, Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 · DOI
  9. 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS II), Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 · DOI
  10. Doughty, 1997, Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease, J Am Coll Cardiol, 29, 1060, 10.1016/S0735-1097(97)00012-0 · DOI
  11. Konstam, 1992, Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure, Circulation, 86, 431, 10.1161/01.CIR.86.2.431 · DOI
  12. Greenberg, 1995, Effect of long-term enalapril on cardiac structure and function in patients with left ventricular dysfunction, Circulation, 91, 2573, 10.1161/01.CIR.91.10.2573 · DOI
  13. Eaton, 1981, Expansion of acute myocardial infraction, Circ Res, 49, 80, 10.1161/01.RES.49.1.80 · DOI
  14. Hochman, 1982, Expansion of acute myocardial infarction; an experimental study, Circulation, 65, 1446, 10.1161/01.CIR.65.7.1446 · DOI
  15. Korup, 1997, Comparisons of degrees of left ventricular dilation within 3 hours and up to 6 days after onset of first acute myocardial infarction, Am J Cardiol, 80, 449, 10.1016/S0002-9149(97)00393-7 · DOI
  16. Hutchins, 1978, Infarct expansion extension, Am J Cardiol, 41, 1127, 10.1016/0002-9149(78)90869-X · DOI
  17. Weisman, 1985, Global cardiac remodeling after acute myocardial infarction, Am J Cardiol, 5, 1355, 10.1016/S0735-1097(85)80348-X · DOI
  18. Rumberger, 1993, Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans, J Am Coll Cardiol, 21, 673, 10.1016/0735-1097(93)90100-F · DOI
  19. Jugdutt, 1995, Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model, J Am Coll Cardiol, 25, 1718, 10.1016/0735-1097(95)00040-B · DOI
  20. Anversa, 1991, Cellular basis of ventricular remodeling after myocardial infarction, Am J Cardiol, 68, 7D, 10.1016/0002-9149(91)90256-K · DOI
  21. McKay, 1986, Left ventricular remodeling after myocardial infarction, Circulation, 74, 693, 10.1161/01.CIR.74.4.693 · DOI
  22. Gaudron, 1993, Progressive left ventricular dysfunction and remodeling after myocardial infarction, Circulation, 87, 755, 10.1161/01.CIR.87.3.755 · DOI
  23. Olivetti, 1990, Side-to-side slippage of myocytes in ventricular wall remodeling acutely after myocardial infarction in rats, Circ Res, 67, 23, 10.1161/01.RES.67.1.23 · DOI · Paper page
  24. Weber, 1991, Pathological hypertrophy and the cardiac interstitium, Circulation, 83, 1849, 10.1161/01.CIR.83.6.1849 · DOI
  25. White, 1987, Left ventricular end-systolic volume as the major determinant of survival after recovery from endomyocardial infarction, Circulation, 76, 44, 10.1161/01.CIR.76.1.44 · DOI
  26. Douglas, 1989, Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy, J Am Coll Cardiol, 13, 311, 10.1016/0735-1097(89)90504-4 · DOI
  27. Mitchell, 1992, Left ventricular remodeling in the year after first anterior myocardial infarction, J Am Coll Cardiol, 19, 1136, 10.1016/0735-1097(92)90314-D · DOI
  28. Hirose, 1993, Right ventricular dilatation and remodeling the first year after an initial transmural wall left ventricular myocardial infarction, Am J Cardiol, 72, 1126, 10.1016/0002-9149(93)90980-Q · DOI
  29. Struijker-Boudier, 1995, Pharmacology of cardiac and vascular remodeling, Ann Rev Pharmacol Toxicol, 35, 509, 10.1146/annurev.pa.35.040195.002453 · DOI
  30. Tan, 1991, Cardiac myocyte necrosis induced by angiotensin II, Circ Res, 69, 1185, 10.1161/01.RES.69.5.1185 · DOI
  31. Sharov, 1996, Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure, Am J Pathol, 148, 141
  32. Teiger, 1996, Apoptosis in pressure overload-induced heart hypertrophy in the rat, J Clin Invest, 97, 2891, 10.1172/JCI118747 · DOI
  33. Olivetti, 1997, Apoptosis in the failing human heart, N Engl J Med, 336, 1131, 10.1056/NEJM199704173361603 · DOI · Paper page
  34. Anderson, 1978, Histopathological types of cardiac fibrosis in myocardial disease, J Pathol, 128, 79, 10.1002/path.1711280205 · DOI
  35. Weber, 1990, Fibrillar collagen and remodeling of dilated canine left ventricle, Circulation, 82, 1387, 10.1161/01.CIR.82.4.1387 · DOI
  36. Villareal, 1993, Identification of functional angiotensin II receptors on rat cardiac fibroblasts, Circulation, 88, 2849, 10.1161/01.CIR.88.6.2849 · DOI
  37. Reiss, 1993, ANG II receptors, c-myc and c-jun in myocytes after myocardial infarction and ventricular failure, Am J Physiol, 264, H760
  38. Sadoshima, 1993, Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype, Circ Res, 73, 413, 10.1161/01.RES.73.3.413 · DOI
  39. Everett, 1994, Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression, Hypertension, 23, 587, 10.1161/01.HYP.23.5.587 · DOI
  40. Belch, 1991, Oxygen free radicals and congestive heart failure, Br Heart J, 65, 245, 10.1136/hrt.65.5.245 · DOI
  41. Ferrari, 1998, Oxidative stress during myocardial ischemia and heart failure, Eur Heart J, 19, S138
  42. Rumberger, 1994, Ventricular dilation and remodeling after myocardial infarction, Mayo Clinic Proc, 69, 664, 10.1016/S0025-6196(12)61345-7 · DOI
  43. Chidsey, 1963, Myocardial norepinephrine concentrations in man, N Engl J Med, 269, 653, 10.1056/NEJM196309262691302 · DOI
  44. Francis, 1990, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure, Circulation, 82, 1724, 10.1161/01.CIR.82.5.1724 · DOI
  45. Torre-Amione, 1996, Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction, J Am Coll Cardiol, 27, 1201, 10.1016/0735-1097(95)00589-7 · DOI · Paper page
  46. McClure, 1998, Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care, BMJ, 317, 516, 10.1136/bmj.317.7157.516 · DOI
  47. Vantrimpont, 1998, Two-year course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) study, Eur Heart J, 19, 1552, 10.1053/euhj.1998.1093 · DOI
  48. Sadoshima, 1993, Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vivo, Cell, 75, 977, 10.1016/0092-8674(93)90541-W · DOI · Paper page
  49. Ollivier J-P, Bouchet VA. Prospects for cardioreparation. Am J Cardiol 1992;70:27–36C. · DOI
  50. Brilla, 1994, Collagen metabolism in cultured adult rat cardiac fibroblasts, J Mol Cell Immunol, 26, 809
  51. Sheehan, 1984, Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease, Magnesium, 3, 301
  52. McMurray, 1992, Plasma endothelin in chronic heart failure, Circulation, 85, 1374, 10.1161/01.CIR.85.4.1374 · DOI
  53. Kiowski, 1995, Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure, Lancet, 346, 732, 10.1016/S0140-6736(95)91504-4 · DOI
  54. Mulder, 1998, Selective ETAblockade prevents left ventricular remodeling and deterioration of cardiac function in experimental models of heart failure, Circ Res, 39, 600
  55. McMurray, 1991, Increased concentrations of tumour necrosis factor in cachectic patients with severe chronic heart failure, Br Heart J, 66, 356, 10.1136/hrt.66.5.356 · DOI
  56. Bozkurt, 1998, Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats, Circulation, 97, 1382, 10.1161/01.CIR.97.14.1382 · DOI · Paper page
  57. Ferrari, 1991, The occurrence of oxidative stress during reperfusion in experimental animals and men, Cardiovasc Drug Ther, 5, 277, 10.1007/BF00054749 · DOI
  58. McMurray, 1993, Evidence of oxidative stress in chronic heart failure in humans, Eur Heart J, 14, 1493, 10.1093/eurheartj/14.11.1493 · DOI
  59. Singh, 1995, Oxidative stress and heart failure, Mol Cell Biochem, 147, 77, 10.1007/BF00944786 · DOI
  60. Hill, 1996, Antioxidant and oxidative stress changes during heart failure subsequent myocardial infarction in rats, Am J Pathol, 148, 291
  61. Polunovsky, 1994, Induction of endothelial cell apoptosis by TNF alpha modulation by inhibitors of protein synthesis, Exp Cell Res, 214, 584, 10.1006/excr.1994.1296 · DOI
  62. Hermann, 1997, Sheer stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase, Arterioscler Throm Vasc Biol, 17, 3588, 10.1161/01.ATV.17.12.3588 · DOI
  63. Francis, 1992, Left ventricular hypertrophy, Am J Cardiol, 69, 3G, 10.1016/0002-9149(92)91249-4 · DOI
  64. Dhalla NS, Kaura D, Liu X, Beamish RE. Mechanisms of subcellular remodeling in postinfarct heart failure. In: Konstam M, editor. Myocardial Ischemia: Mechanisms, Reperfusion, Protection. Birkhauser Verlag Basel: Basel, Switzerland 1996:463–77. · DOI
  65. Van Krimpen, 1991, DNA synthesis in the noninfarcted cardiac interstitium after left coronary artery ligation in the rat, J Mol Cell Cardiol, 23, 1245, 10.1016/0022-2828(91)90082-W · DOI
  66. Volders, 1993, Interstitial collagen is increased in the noninfarcted human myocardium after myocardial infarction, J Mol Cell Cardiol, 25, 1317, 10.1006/jmcc.1993.1144 · DOI
  67. Tyagi, 1993, Direct extraction and estimation of collagenase(s) activity by zymograph in microquantities of rat myocardium and uterus, Clin Biochem, 26, 191, 10.1016/0009-9120(93)90025-2 · DOI
  68. Cleutjens, 1995, Regulation of collagen degradation in the rat myocardium after infarction, J Mol Cell Cardiol, 27, 1281, 10.1016/S0022-2828(05)82390-9 · DOI
  69. Delong, 1998, Apoptosis, Ann NY Acad Sci, 842, 82, 10.1111/j.1749-6632.1998.tb09635.x · DOI
  70. Kajstura, 1998, Myocyte proliferation in end stage cardiac failure in humans, Proc Natl Acad Sci, 95, 8801, 10.1073/pnas.95.15.8801 · DOI
  71. Meerson FZ. The failing heart: adaptation and deadaptation: XVII. In: Katz J, Editor. Translated from Russian by Nicholas Bobrov and Leonid Levant. New York: Raven Press, 1983.
  72. Sabbah, 1993, Ventricular remodeling, Eur Heart J, 14, 24, 10.1093/eurheartj/14.suppl_C.24 · DOI
  73. Hammermeister, 1979, Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic and quantitative angiographic values, Circulation, 59, 421, 10.1161/01.CIR.59.3.421 · DOI
  74. Pfeffer, 1990, Ventricular remodeling after myocardial infarction, Circulation, 81, 1161, 10.1161/01.CIR.81.4.1161 · DOI
  75. Carr, 1985, Detection of hypertensive left ventricular hypertrophy, Hypertension, 7, 948, 10.1161/01.HYP.7.6.948 · DOI
  76. Kannel, 1996, Need and prospects for prevention of heart failure, Eur J Clin Pharmacol, 49, S3
  77. Cohn, 1993, Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure, Circulation, 87, VI5
  78. Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 · DOI · Paper page
  79. Lechat, 1997, Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS), Circulation, 96, 2197, 10.1161/01.CIR.96.7.2197 · DOI
  80. White, 1987, Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction, Circulation, 76, 44, 10.1161/01.CIR.76.1.44 · DOI
  81. Cleland, 1995, Guidelines for the diagnosis of heart failure, Eur Heart J, 16, 741
  82. McDonagh, 1997, Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population, Lancet, 350, 829, 10.1016/S0140-6736(97)03033-X · DOI
  83. McMurray, 1998, Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?, Eur Heart J, 19, 842, 10.1093/eurheartj/19.6.842 · DOI
  84. Gottdiener, 1993, Left ventricular mass, diastolic dysfunction and hypertension, Ann Intern Med, 38, 31
  85. Francis, 1995, Open access echocardiography in management of heart failure in the community, Br Med J, 310, 634, 10.1136/bmj.310.6980.634 · DOI
  86. Krzesinski, 1996, Hypertension and left ventricular hypertrophy, Acta Cardiologica, 51, 143
  87. Gradman, 1989, Predictors of total mortality and sudden death in mild to moderate heart failure, J Am Coll Cardiol, 14, 464, 10.1016/0735-1097(89)90093-4 · DOI
  88. Parameshwar, 1992, Predictors of prognosis in severe chronic heart failure, Am Heart J, 123, 421, 10.1016/0002-8703(92)90656-G · DOI
  89. Likoff, 1987, Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy, Am J Cardiol, 59, 634, 10.1016/0002-9149(87)91183-0 · DOI
  90. Cintron, 1993, Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure, Circulation, 87, VI17
  91. Cowie, 1997, Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care, Lancet, 350, 1349, 10.1016/S0140-6736(97)06031-5 · DOI
  92. Ferrari, 1998, Neuroendocrine activation in left ventricular dysfunction [editorial], Eur Heart J, 19, 1423
  93. Cohn, 1997, Effect of the calcium antagonist felodipine as supplementary therapy in patients with chronic heart failure treated with enalapril, Circulation, 96, 856, 10.1161/01.CIR.96.3.856 · DOI
  94. Sharpe, 1988, Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction, Lancet, 1, 253
  95. Swedberg, 1992, Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction, N Engl J Med, 327, 678, 10.1056/NEJM199209033271002 · DOI
  96. 1987, Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 · DOI
  97. 1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure, Lancet, 342, 821
  98. Kober, 1995, A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 333, 1670, 10.1056/NEJM199512213332503 · DOI
  99. 1994, GISSI 3, Lancet, 343, 1115
  100. Nicolosi, 1996, The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects if early lisinopril treatment on left ventricular structure and function after myocardial infarction in the GISSI-3 trial, Eur Heart J, 17, 1646, 10.1093/oxfordjournals.eurheartj.a014747 · DOI
  101. 1994, A randomized trial of beta-blockade in heart failure, Circulation, 90, 1765, 10.1161/01.CIR.90.4.1765 · DOI
  102. Colucci, 1996, Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure, Circulation, 94, 2800, 10.1161/01.CIR.94.11.2800 · DOI
  103. Bristow, 1996, Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure, Circulation, 94, 2807, 10.1161/01.CIR.94.11.2807 · DOI · Paper page
  104. Gilbert, 1990, Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy, Am J Med, 88, 223, 10.1016/0002-9343(90)90146-5 · DOI
  105. Lowes, 1999, Effects of carvedilol on left ventricular mass, chamber geometry and mitral regurgitation in chronic heart failure, Am J Cardiol, 83, 1201, 10.1016/S0002-9149(99)00059-4 · DOI
  106. Basu, 1997, Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled randomized trial, Circulation, 96, 183, 10.1161/01.CIR.96.1.183 · DOI
  107. 1982, A Randomized trial of propranolol in patients with acute myocardial infarction, J Am Med Assoc, 247, 1707, 10.1001/jama.1982.03320370021023 · DOI
  108. 1981, Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction, N Engl J Med, 304, 801, 10.1056/NEJM198104023041401 · DOI
  109. Cohn, 1973, Vasodilator therapy for heart failure, Circulation, 48, 5, 10.1161/01.CIR.48.1.5 · DOI
  110. McDonald, 1993, Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog, J Am Coll Cardiol, 21, 514, 10.1016/0735-1097(93)90697-Y · DOI
  111. Lubsen, 1996, Effect of pimobendan on exercise capacity in patients with heart failure, Heart, 76, 223, 10.1136/hrt.76.3.223 · DOI
  112. Hampton, 1997, Randomized study of effect of ibopamine on survival in patients with advanced severe heart failure, Lancet, 349, 971, 10.1016/S0140-6736(96)10488-8 · DOI
  113. Cohn, 1998, A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure, N Engl J Med, 339, 1810, 10.1056/NEJM199812173392503 · DOI
  114. Beckwith, 1993, Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction, Ann Pharmacother, 27, 755, 10.1177/106002809302700617 · DOI
  115. Pfeffer, 1987, Effect of captopril on progressive ventricular dilation after anterior myocardial infarction, N Engl J Med, 317, 787
  116. Woodley, 1991, Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy, Circulation, 84, 2426, 10.1161/01.CIR.84.6.2426 · DOI
  117. Packer, 1996, Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial, Circulation, 94, 2793, 10.1161/01.CIR.94.11.2793 · DOI
  118. Cohn, 1997, Safety and efficacy of carvedilol in severe heart failure, J Card Fail, 3, 173, 10.1016/S1071-9164(97)90013-0 · DOI
  119. Waagstein, 1989, Long-term beta-blockade in dilated cardiomyopathy. Effects of short and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol, Circulation, 80, 551, 10.1161/01.CIR.80.3.551 · DOI
  120. Hall, 1995, Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade, J Am Coll Cardiol, 25, 1154, 10.1016/0735-1097(94)00543-Y · DOI
  121. Kukin, 1999, Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction and oxidative stress in heart failure, Circulation, 99, 2645, 10.1161/01.CIR.99.20.2645 · DOI
  122. Packer, 1998, Beta-adrenergic blockade in chronic heart failure, Prog Cardiovasc Dis, 41, 39, 10.1016/S0033-0620(98)80030-3 · DOI
  123. Sackner-Bernstein, 1998, Use of carvedilol in chronic heart failure, Prog Cardiovasc Dis, 41, 53, 10.1016/S0033-0620(98)80031-5 · DOI

Cited by

Sorted by citations

Metadata

Authors
Cohn, J. N., Ferrari, R., & Sharpe, N.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2000-03
Volume
35
Issue
3
Pages
569-582
ISSN
0735-1097
DOI
10.1016/s0735-1097(99)00630-0
Cited by
2,161
References
8
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review